Research output per year
Research output per year
Personal profile
Specialisation
Gastroenterology. Mucosal immunology in inflammatory Bowel Disease
Research interests
My research focuses on understanding the pathogenesis of immune-based gastrointestinal diseases with a main focus on inflammatory bowel disease (IBD) and cancer. The ultimate goal is to find new therapies for these diseases.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, PhD Life and death at the mucosal luminal interface: a new perspective on human intestinal ischemia-reperfusion, Maastricht University
2007 → 2011
Award Date: 2 Nov 2012
Master, Medical Doctor degree, Maastricht University
2001 → 2007
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila
Matute, J. D., Duan, J., Flak, M. B., Griebel, P., Tascon-Arcila, J. A., Doms, S., Hanley, T., Antanaviciute, A., Gundrum, J., Mark Welch, J. L., Sit, B., Abtahi, S., Fuhler, G. M., Grootjans, J., Tran, F., Stengel, S. T., White, J. R., Krupka, N., Haller, D., Clare, S., & 11 others, 2 Jan 2023, In: Journal of Experimental Medicine. 220, 1, e20211938.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Initiative on Crohn and Colitis, Jan 2023, In: Clinical Gastroenterology and Hepatology. 21, 1, p. 182-191.e2Research output: Contribution to journal › Article › Academic › peer-review
Open Access8 Citations (Scopus) -
Emerging therapies for ulcerative colitis
Hanzel, J., Hulshoff, M. S., Grootjans, J. & D’Haens, G., 2022, In: Expert review of clinical immunology. 18, 5, p. 513-524 12 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access2 Citations (Scopus) -
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis, Sep 2022, In: Alimentary Pharmacology and Therapeutics. 56, 6, p. 1044-1054 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access6 Citations (Scopus) -
Temporal Transcript Profiling Identifies a Role for Unfolded Protein Stress in Human Gut Ischemia-Reperfusion Injury
Kip, A. M., Grootjans, J., Manca, M., Hadfoune, M., Boonen, B., Derikx, J. P. M., Biessen, E. A. L., Olde Damink, S. W. M., Dejong, C. H. C., Buurman, W. A. & Lenaerts, K., Jan 2022, In: CMGH. 13, 3, p. 681-694 14 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus)
Prizes
-
Amsterdam Gastroenterology & Metabolism Talent development award
Grootjans, Joep (Recipient), 2019
Prize: Other distinction
-
-
-
-